M&A Deal Summary |
|
|---|---|
| Date | 2024-07-09 |
| Target | Fluent BioSciences |
| Sector | Life Science |
| Buyer(s) | Illumina |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 10,590 |
| Revenue | 4.5B USD (2023) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 29 of 29 |
| Sector (Life Science) | 18 of 18 |
| Type (Add-on Acquisition) | 14 of 14 |
| State (Massachusetts) | 2 of 2 |
| Country (United States) | 20 of 20 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-09 |
Verogen
San Diego, California, United States Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California. |
Sell | $150M |
